查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1935755

全球咽喉痛錠劑和糖果市場（按產品類型、口味、包裝類型、銷售管道和最終用戶分類）預測（2026-2032年）

Sore Throat Lozenges & Candy Market by Product Type, Flavor, Packaging Type, Sales Channel, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，潤喉糖和糖果市場價值將達到 49.3 億美元，到 2026 年將成長至 53.3 億美元，年複合成長率為 8.40%，到 2032 年將達到 86.7 億美元。

關鍵市場統計數據
基準年 2025 49.3億美元
預計年份：2026年 53.3億美元
預測年份 2032 86.7億美元
複合年成長率 (%) 8.40%

策略實施：消費者健康趨勢、監管壓力和不斷變化的零售業如何重塑產品開發和商業性重點。

本執行摘要探討了影響全球咽喉糖和藥用糖果市場的競爭格局、消費者趨勢和產品創新趨勢。近期推出的新產品和配方改良都強調了產品的多功能性，將植物成分和天然甜味劑結合，以緩解症狀並增強免疫力，這不僅改變了消費者的預期，也改變了零售商的產品組合。同時，對活性成分日益嚴格的監管審查，以及數位化零售的快速普及，正迫使企業改善標籤、產品聲明和全通路分銷策略。

消費者期望的重大轉變、原料創新以及全通路零售正在重新定義產品開發、證據要求和市場推廣策略。

由於消費者健康意識的增強、通路的重組以及成分創新，潤喉糖和糖片市場格局正在轉變。消費者現在尋求的是既能緩解症狀又能促進健康的配方，而不僅僅是掩蓋症狀的產品。這促使製造商將傳統活性成分與植物萃取物和功能性補充劑結合。這種轉變推動了香料製造商、植物原料供應商和臨床配方開發人員之間的跨學科合作，最終加速了產品差異化的進程。

2025年美國關稅調整對錠劑和錠劑類產品的採購決策、供應鏈韌性和商業性定價策略的影響

2025年美國關稅調整的累積影響迫使許多公司重新評估其潤喉糖和糖果甜點類藥品的採購、製造地和跨境物流。某些進口原料和成品關稅的提高增加了到岸成本，促使企業重新評估供應商關係，導致近岸外包和雙重籌資策略激增，以維持利潤率的穩定性和供應的連續性。

將產品形式、分銷通路特徵、口味偏好、終端用戶需求和包裝選擇與競爭優勢和創新重點連結起來的綜合細分分析

細分市場洞察揭示了產品、通路、口味、終端用戶和包裝等維度上創新、獲利機會和通路效率的交匯點。依產品類型分類，市場分析涵蓋硬錠劑、藥糖和軟錠劑。硬錠劑進一步細分為尤加利、草藥萃取物和薄荷醇三種類型。這種產品分類突顯了技術和感官設計方面的差異：硬錠劑通常需要配製延長與咽喉的接觸時間，並平衡溶解度和活性成分的釋放。而軟錠劑和藥糖則提供了添加適應更高水分含量成分的機會，並可創造新的質地以提升偏好。

關鍵區域洞察：揭示管理體制、消費者偏好特徵和分銷模式如何影響美洲、歐洲、中東和非洲以及亞太地區的策略。

區域趨勢差異顯著，影響企業必須採取的競爭策略和監管應對措施。美洲的特點是零售基礎設施成熟、藥房生態系統強大，以及直接面對消費者（DTC）的通路發達。監管重點包括清晰的標籤和有據可依的療效聲明，而消費者偏好也日益傾向於天然和低糖產品。美洲的轉型市場仍為教育行銷提供了巨大空間，可以將產品類別從緩解急性症狀擴展到「健康養生」領域。

洞察競爭行為：揭示製劑技術、監管能力和策略聯盟如何決定差異化、通路策略和夥伴關係活動

公司策略圍繞著配方技術、市場推廣策略、法規事務和品牌建立等核心競爭力。主要企業正加大對配方科學的投入，力求在功效、口感和貨架穩定性之間取得平衡，同時利用合作生產夥伴關係擴大生產規模，而不損害其核心競爭力。擁有強大法規事務能力的公司在支持複雜的聲明和加速跨區域產品上市方面具有優勢。

實際的優先建議，幫助產品系列、證明自身價值、加強供應鏈，並在數位化和傳統通路中取得成功

為了將洞察轉化為永續的競爭優勢，產業領導者應採取一系列切實可行且基於實證的行動。首先，應優先進行產品組合最佳化，使產品與特定通路的價值提案相匹配，減少造成交易複雜性的SKU，同時專注於能夠促進核心通路重複購買的產品規格和口味。其次，應透過有針對性的消費者使用研究以及在條件允許的情況下進行小規模臨床檢驗，加快產品功效驗證，從而在藥房和健康管道中實現清晰的市場定位。

本報告的研究採用了一種透明、多方面的調查方法，包括一手檢驗、有針對性的調查、二手資料的三角驗證以及品管，以檢驗研究結果。

本報告的研究結合了第一手資料和第二手資料，以確保研究的嚴謹性、可重複性和相關性。第一手資料包括對製造商、零售買家、採購主管和監管專家進行結構化訪談，以了解營運觀點並檢驗商業性假設。此外，我們還針對具有代表性的消費者群體進行了目標調查，以探討其購買動機、口味偏好和管道選擇標準，從而補充了這些定性研究成果。

對產品創新、通路差異化和供應鏈韌性的全面分析，為商業決策提供清晰的指南。

總而言之，潤喉糖和舒緩醣品類正處於一個轉折點，產品創新、分銷管道轉型和供應鏈適應性將在此交匯，共同決定最終的商業性贏家。將經證實有效的緩解症狀功效與消費者喜愛的成分和口味相結合的產品開發，將在藥局和一般分銷管道都獲得青睞。同時，可靠的療效證據和完善的監管準備將使真正有價值的提案在眾多產品中脫穎而出。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依產品類型分類的咽喉痛潤喉糖和糖果市場

  • 硬錠劑
    • 尤加利
    • 草藥萃取物
    • 薄荷醇
  • 藥用糖果
  • 軟錠劑

9. 依口味分類的咽喉痛潤喉糖和糖果市場

  • 水果
  • 草藥
  • 蜂蜜
  • 薄荷醇

10. 依包裝類型分類的咽喉痛潤喉糖和糖果市場

  • 泡殼包裝
  • 流式包裝
  • 瓶子

第11章 依銷售管道分類的咽喉痛潤喉糖市場

  • 便利商店
  • 網路商店
  • 藥局
  • 超級市場和大賣場

第12章 最終使用者視野下的咽喉痛潤喉糖和糖果市場

  • 成人版
  • 兒童

第13章 各地區的咽喉痛喉糖和糖果市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 按群體分類的咽喉痛潤喉糖和糖果市場

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

15. 各國喉嚨痛潤喉糖和糖果市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

16. 美國喉嚨痛潤喉糖和糖果市場

第17章 中國潤喉糖和糖果市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Boiron USA, Inc.
  • Church & Dwight Co., Inc.
  • GlaxoSmithKline Plc.
  • Haleon plc
  • Hyland's, Inc.
  • Johnson & Johnson Services, Inc.
  • Mondelez International, Inc.
  • Prestige Consumer Healthcare Inc.
  • Reckitt Benckiser Group plc
  • Ricola AG
  • Sanofi SA
  • Thornton & Ross Ltd.
Product Code: MRR-9A6A6F297517

The Sore Throat Lozenges & Candy Market was valued at USD 4.93 billion in 2025 and is projected to grow to USD 5.33 billion in 2026, with a CAGR of 8.40%, reaching USD 8.67 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 4.93 billion
Estimated Year [2026] USD 5.33 billion
Forecast Year [2032] USD 8.67 billion
CAGR (%) 8.40%

A strategic introduction outlining how consumer health preferences, regulatory pressures, and retail evolution are reshaping product development and commercial priorities

This executive summary introduces the competitive environment, consumer drivers, and product innovation trends shaping the global sore throat lozenges and medicinal candy category. Recent product launches and reformulation efforts have emphasized multifunctionality, combining symptomatic relief with immune-supporting botanicals and natural sweeteners, and these developments have altered both consumer expectations and retail assortments. At the same time, the interplay between regulatory scrutiny on active ingredients and accelerating digital retail adoption has required companies to refine labeling, claims, and omnichannel merchandising.

To set context, the category spans everyday symptomatic relief formats as well as perceived wellness confections that appeal to a broader health-conscious audience. Consumers are increasingly discerning about ingredient provenance, sugar content, and functional claims, while payers and pharmacy channels scrutinize efficacy statements. Concurrently, manufacturers are pursuing lightweight packaging innovations and sustainable materials to respond to both retailer requirements and end-consumer preferences.

Throughout this introduction, the goal is to orient decision-makers to the primary forces influencing product development, channel strategy, and competitive differentiation. By understanding these drivers, executives can better prioritize investments in R&D, regulatory support, and channel-specific promotion that align with evolving consumer demands and commercial realities.

Major shifts in consumer expectations, ingredient innovation, and omnichannel retailing that are redefining product development, evidence requirements, and go-to-market tactics

The landscape for sore throat lozenges and medicated candy is undergoing transformative shifts driven by consumer health awareness, channel reinvention, and ingredient innovation. Consumers now expect products that do more than mask symptoms; they seek formulations that combine relief with perceived wellness benefits, prompting manufacturers to blend traditional actives with botanical extracts and functional adjuncts. This evolution has encouraged cross-disciplinary partnerships between flavor houses, botanical suppliers, and clinical formulators, which in turn has accelerated the pace of product differentiation.

Meanwhile, retail distribution has evolved beyond traditional pharmacy and supermarket shelves. E-commerce growth and subscription models have created new avenues for direct-to-consumer engagement, enabling brands to gather first-party data and tailor communications. This shift requires novel logistics, including temperature- and humidity-aware packaging for certain formulations, and it incentivizes brands to invest in digital content that effectively communicates benefits and usage.

Regulatory and labeling expectations have tightened in several jurisdictions, prompting more rigorous evidence collection and transparent ingredient communication. In response, firms are adopting more robust claim substantiation practices and investing in clinical or consumer usage studies. Taken together, these shifts are transforming how products are conceived, validated, marketed, and delivered, creating a dynamic environment where speed-to-market and credibility are both crucial.

How the 2025 United States tariff adjustments have reshaped sourcing decisions, supply chain resilience, and commercial pricing strategies across the lozenges and medicinal candy category

The cumulative impact of tariff adjustments implemented by the United States in 2025 has prompted many firms to reassess sourcing, manufacturing footprint, and cross-border logistics for throat lozenges and confectionery-based medicinal products. Tariff increases on certain imported ingredients and finished goods raised landed costs and catalyzed a re-evaluation of supplier relationships, leading to a wave of nearshoring conversations and dual-sourcing strategies to preserve margin resilience and supply continuity.

In practice, procurement teams responded by conducting cost-to-serve analyses and by accelerating qualification processes for alternate suppliers within more favorable trade zones. Where reformulation was feasible without compromising efficacy or compliance, manufacturers evaluated domestic ingredient substitutes or modified packaging to minimize tariff exposure. For those unwilling or unable to alter supply chains quickly, companies absorbed short-term cost increases while negotiating with retailers and distributors for adjusted trade terms and promotional support.

Additionally, tariff-induced complexity increased the importance of customs classification, harmonized system codes, and tariff engineering strategies. Firms invested in enhanced tariff monitoring and scenario planning to understand implications for product portfolios and channel profitability. The net effect was a strategic pivot toward greater supply chain agility and an emphasis on commercial models that mitigate the financial and operational uncertainty introduced by the 2025 tariff landscape.

Comprehensive segmentation analysis linking product form, channel behavior, flavor preferences, end-user needs, and packaging choices to competitive advantage and innovation focus

Segment-level insight illuminates where innovation, margin opportunity, and channel effectiveness intersect across product, channel, flavor, end-user, and packaging dimensions. Based on Product Type, market is studied across Hard Lozenges, Medicinal Candy, and Soft Lozenges. The Hard Lozenges is further studied across Eucalyptus, Herbal Extract, and Menthol. This product taxonomy highlights distinct technical and sensory design constraints: hard lozenges typically emphasize prolonged throat contact and are formulated to balance dissolvability with active delivery, whereas soft lozenges and medicinal candies enable inclusion of higher moisture-compatible ingredients and novel textures aimed at palatability.

Based on Sales Channel, market is studied across Convenience Store, Online Store, Pharmacy, and Supermarket And Hypermarket. Each channel exhibits different purchase motivators and shelf velocity patterns, with pharmacies prioritizing clinically positioned SKUs, supermarkets focusing on impulse and family-size packs, convenience stores optimizing for portability and price, and online stores enabling subscription and bundling strategies. Based on Flavor, market is studied across Fruit, Herbal, Honey, and Menthol. Flavor selection directly affects trial and repeat purchase rates, with menthol and herbal profiles skewing toward therapeutic positioning while fruit and honey flavors facilitate mainstream adoption and cross-demographic appeal.

Based on End User, market is studied across Adult and Pediatric. Pediatric formulations demand stricter flavor masking, smaller dosing, and child-friendly packaging formats, creating separate formulation and regulatory pathways. Based on Packaging Type, market is studied across Blister Pack, Flow Pack, and Jar. Packaging choices influence shelf life, merchandising ergonomics, and unit economics; blister packs often support precise dosing and regulatory compliance, flow packs enable high-velocity retailing, and jars cater to multi-dose household usage. Synthesizing these segmentation lenses reveals where to focus R&D, promotional investment, and channel-specific differentiation to unlock competitive advantage.

Key regional intelligence highlighting how regulatory regimes, consumer taste profiles, and distribution models shape strategy across the Americas, Europe Middle East & Africa, and Asia-Pacific

Regional dynamics vary significantly and shape the competitive and regulatory playbooks that companies must adopt. Americas often feature a mature retail infrastructure with strong pharmacy ecosystems and a robust direct-to-consumer presence; regulatory expectations prioritize clear labeling and substantiation for therapeutic claims, while consumer preferences increasingly tilt toward natural and low-sugar options. In transitional markets within the Americas, there is still meaningful room for educational marketing to expand category usage beyond acute symptomatic relief into perceived wellness use cases.

Europe, Middle East & Africa presents a heterogeneous landscape in which regulatory regimes and distribution models differ markedly. Western European markets emphasize clinical evidence and sustainability credentials, while certain Middle Eastern and African markets prioritize affordability and distribution reach. Multinational players therefore adopt differentiated regulatory strategies and distribution partnerships, and they often tailor assortments to local palate and pricing expectations.

Asia-Pacific displays dynamic product innovation and rapid channel evolution, with pronounced growth in online pharmacy platforms and mobile-first commerce. Consumers in several Asia-Pacific markets have strong flavor preferences that influence formulation choices and localized product development. Across all regions, logistics considerations, regulatory timelines, and cultural norms shape product assortment and promotional strategy. By aligning commercial plans with these regional nuances, firms can optimize assortment, compliance, and channel investments to resonate with local demand drivers.

Insight into competitive behaviors showing how formulation skills, regulatory capabilities, and strategic collaborations determine differentiation, channel focus, and partnership activity

Company strategies cluster around a few core capabilities: formulation expertise, route-to-market proficiency, regulatory navigation, and brand building. Leading firms invest in formulation science to balance efficacy, taste, and shelf stability, while also leveraging co-manufacturing partnerships to scale production without diluting core competencies. Companies that have cultivated robust regulatory affairs functions are better positioned to support nuanced claims and accelerate product introductions across jurisdictions.

In terms of commercial positioning, some companies pursue premium, clinically validated propositions targeted at pharmacy channels, while others emphasize everyday wellness positioning distributed through supermarkets and convenience stores. Strategic collaborations between established pharmaceutical manufacturers and nimble consumer brands are increasingly common, enabling the combination of clinical credibility with agile marketing and direct-to-consumer capabilities. Similarly, acquisition activity and licensing arrangements are tools used to access niche flavors, botanical extracts, or patented delivery technologies that offer competitive differentiation.

Finally, organizations that integrate category intelligence into cross-functional decision-making - linking insights from sales, supply chain, and R&D - tend to execute more coherent launch plans and pricing strategies. These firms also have a clearer view of where to concentrate investment, whether that is in sensory science to improve palatability for pediatric lines or in sustainable packaging to meet retailer and consumer expectations.

Practical and prioritized recommendations to strengthen product portfolios, substantiate claims, fortify supply chains, and win across both digital and traditional channels

Industry leaders should pursue a set of pragmatic, evidence-based actions to convert insight into sustained competitive advantage. First, prioritize portfolio rationalization that aligns products with channel-specific value propositions, reducing SKUs that create trade complexity while doubling down on formats and flavors that drive repeat purchase in core channels. Next, accelerate claim substantiation through targeted consumer use studies and small-scale clinical validation where feasible, thereby enabling clearer positioning in pharmacy and health-oriented channels.

Simultaneously, strengthen supply chain resilience by cultivating dual-source strategies for critical actives and by evaluating nearshoring options for packaging or finished goods. Investing in tariff and customs expertise will reduce cost volatility and allow for more predictable commercial planning. On the commercial front, adopt an omnichannel content strategy that tailors messaging to discovery moments on e-commerce platforms while reinforcing credibility through pharmacist-facing educational materials in retail channels.

Finally, embed sustainability and accessibility into product and packaging roadmaps to meet evolving retailer requirements and consumer expectations. By sequencing these actions-portfolio focus, evidence generation, supply chain fortification, and omnichannel commercialization-leaders can reduce risk, improve margin resilience, and accelerate adoption of higher-value product tiers.

A transparent, multi-method research approach describing primary interviews, targeted surveys, secondary data triangulation, and quality controls that validate insights

The research underpinning this report combines primary and secondary approaches to ensure rigor, reproducibility, and relevance. Primary research included structured interviews with manufacturers, retail buyers, procurement leads, and regulatory specialists to capture operational perspectives and validate commercial assumptions. These qualitative insights were complemented by targeted surveys designed to explore purchase drivers, flavor preferences, and channel selection criteria across representative consumer cohorts.

Secondary research drew on public regulatory filings, patent and ingredient registries, industry trade publications, and retailer assortment data to map product portfolios and distribution footprints. Data synthesis employed triangulation methods to reconcile divergent findings, and quality controls included source verification, consistency checks, and peer review by subject-matter analysts. Assumptions were documented and stress-tested through scenario analysis to understand sensitivity to changes in input parameters such as raw material access or regulatory timelines.

Ethical research practices and confidentiality agreements governed primary engagement with corporate respondents, and data anonymization was used where required to protect commercial sensitivities. This layered methodological approach ensures that findings are grounded in both practitioner insight and documentary evidence, enabling robust guidance for strategic decision-making.

A conclusive synthesis that ties together product innovation, channel differentiation, and supply resilience into a clear playbook for executive decision-making

In conclusion, the sore throat lozenges and medicinal candy category is at an inflection point where product innovation, channel transformation, and supply chain adaptability converge to determine commercial winners. Product development that marries proven symptomatic relief with consumer-preferred ingredients and flavors will be favored in both pharmacy and mainstream channels, while robust claim substantiation and regulatory readiness will increasingly separate credible propositions from noise.

Channel strategies must be tailored: pharmacies will reward clinical credibility and professional endorsement, supermarkets and convenience formats will prioritize convenience and familiar flavors, and online platforms will require differentiated content and logistics capabilities. Supply chain and sourcing strategies that incorporate tariff sensitivity and alternative supplier qualification will provide the operational backbone that supports commercial agility.

Taken together, these insights point to a pragmatic playbook for executives: focus investments where product, channel, and regulatory strengths align; build operational resilience to absorb external shocks; and use targeted evidence generation to unlock premium positioning. This integrated approach will help organizations navigate complexity and capture sustainable value across the category.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Sore Throat Lozenges & Candy Market, by Product Type

  • 8.1. Hard Lozenges
    • 8.1.1. Eucalyptus
    • 8.1.2. Herbal Extract
    • 8.1.3. Menthol
  • 8.2. Medicinal Candy
  • 8.3. Soft Lozenges

9. Sore Throat Lozenges & Candy Market, by Flavor

  • 9.1. Fruit
  • 9.2. Herbal
  • 9.3. Honey
  • 9.4. Menthol

10. Sore Throat Lozenges & Candy Market, by Packaging Type

  • 10.1. Blister Pack
  • 10.2. Flow Pack
  • 10.3. Jar

11. Sore Throat Lozenges & Candy Market, by Sales Channel

  • 11.1. Convenience Store
  • 11.2. Online Store
  • 11.3. Pharmacy
  • 11.4. Supermarket And Hypermarket

12. Sore Throat Lozenges & Candy Market, by End User

  • 12.1. Adult
  • 12.2. Pediatric

13. Sore Throat Lozenges & Candy Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Sore Throat Lozenges & Candy Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Sore Throat Lozenges & Candy Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Sore Throat Lozenges & Candy Market

17. China Sore Throat Lozenges & Candy Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Boiron USA, Inc.
  • 18.6. Church & Dwight Co., Inc.
  • 18.7. GlaxoSmithKline Plc.
  • 18.8. Haleon plc
  • 18.9. Hyland's, Inc.
  • 18.10. Johnson & Johnson Services, Inc.
  • 18.11. Mondelez International, Inc.
  • 18.12. Prestige Consumer Healthcare Inc.
  • 18.13. Reckitt Benckiser Group plc
  • 18.14. Ricola AG
  • 18.15. Sanofi S.A.
  • 18.16. Thornton & Ross Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL SORE THROAT LOZENGES & CANDY MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY FLAVOR, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PACKAGING TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES SORE THROAT LOZENGES & CANDY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA SORE THROAT LOZENGES & CANDY MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY HARD LOZENGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY HARD LOZENGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY HARD LOZENGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY HARD LOZENGES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY EUCALYPTUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY EUCALYPTUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY EUCALYPTUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY HERBAL EXTRACT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY HERBAL EXTRACT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY HERBAL EXTRACT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY MENTHOL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY MENTHOL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY MENTHOL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY MEDICINAL CANDY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY MEDICINAL CANDY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY MEDICINAL CANDY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY SOFT LOZENGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY SOFT LOZENGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY SOFT LOZENGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY FRUIT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY FRUIT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY FRUIT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY HERBAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY HERBAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY HERBAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY HONEY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY HONEY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY HONEY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY MENTHOL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY MENTHOL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY MENTHOL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY BLISTER PACK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY BLISTER PACK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY BLISTER PACK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY FLOW PACK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY FLOW PACK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY FLOW PACK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY JAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY JAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY JAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY CONVENIENCE STORE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY CONVENIENCE STORE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY CONVENIENCE STORE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY ONLINE STORE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY ONLINE STORE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY ONLINE STORE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY SUPERMARKET AND HYPERMARKET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY SUPERMARKET AND HYPERMARKET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY SUPERMARKET AND HYPERMARKET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS SORE THROAT LOZENGES & CANDY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS SORE THROAT LOZENGES & CANDY MARKET SIZE, BY HARD LOZENGES, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS SORE THROAT LOZENGES & CANDY MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS SORE THROAT LOZENGES & CANDY MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS SORE THROAT LOZENGES & CANDY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY HARD LOZENGES, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY HARD LOZENGES, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY HARD LOZENGES, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE SORE THROAT LOZENGES & CANDY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE SORE THROAT LOZENGES & CANDY MARKET SIZE, BY HARD LOZENGES, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE SORE THROAT LOZENGES & CANDY MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE SORE THROAT LOZENGES & CANDY MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE SORE THROAT LOZENGES & CANDY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST SORE THROAT LOZENGES & CANDY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST SORE THROAT LOZENGES & CANDY MARKET SIZE, BY HARD LOZENGES, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST SORE THROAT LOZENGES & CANDY MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. MIDDLE EAST SORE THROAT LOZENGES & CANDY MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST SORE THROAT LOZENGES & CANDY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY HARD LOZENGES, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. AFRICA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 114. AFRICA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC SORE THROAT LOZENGES & CANDY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC SORE THROAT LOZENGES & CANDY MARKET SIZE, BY HARD LOZENGES, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC SORE THROAT LOZENGES & CANDY MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC SORE THROAT LOZENGES & CANDY MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC SORE THROAT LOZENGES & CANDY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN SORE THROAT LOZENGES & CANDY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. ASEAN SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. ASEAN SORE THROAT LOZENGES & CANDY MARKET SIZE, BY HARD LOZENGES, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN SORE THROAT LOZENGES & CANDY MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
  • TABLE 127. ASEAN SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. ASEAN SORE THROAT LOZENGES & CANDY MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN SORE THROAT LOZENGES & CANDY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. GCC SORE THROAT LOZENGES & CANDY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GCC SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. GCC SORE THROAT LOZENGES & CANDY MARKET SIZE, BY HARD LOZENGES, 2018-2032 (USD MILLION)
  • TABLE 133. GCC SORE THROAT LOZENGES & CANDY MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
  • TABLE 134. GCC SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. GCC SORE THROAT LOZENGES & CANDY MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 136. GCC SORE THROAT LOZENGES & CANDY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPEAN UNION SORE THROAT LOZENGES & CANDY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPEAN UNION SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPEAN UNION SORE THROAT LOZENGES & CANDY MARKET SIZE, BY HARD LOZENGES, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPEAN UNION SORE THROAT LOZENGES & CANDY MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPEAN UNION SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPEAN UNION SORE THROAT LOZENGES & CANDY MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPEAN UNION SORE THROAT LOZENGES & CANDY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. BRICS SORE THROAT LOZENGES & CANDY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. BRICS SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. BRICS SORE THROAT LOZENGES & CANDY MARKET SIZE, BY HARD LOZENGES, 2018-2032 (USD MILLION)
  • TABLE 147. BRICS SORE THROAT LOZENGES & CANDY MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
  • TABLE 148. BRICS SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. BRICS SORE THROAT LOZENGES & CANDY MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 150. BRICS SORE THROAT LOZENGES & CANDY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. G7 SORE THROAT LOZENGES & CANDY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. G7 SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. G7 SORE THROAT LOZENGES & CANDY MARKET SIZE, BY HARD LOZENGES, 2018-2032 (USD MILLION)
  • TABLE 154. G7 SORE THROAT LOZENGES & CANDY MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
  • TABLE 155. G7 SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. G7 SORE THROAT LOZENGES & CANDY MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 157. G7 SORE THROAT LOZENGES & CANDY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. NATO SORE THROAT LOZENGES & CANDY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. NATO SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. NATO SORE THROAT LOZENGES & CANDY MARKET SIZE, BY HARD LOZENGES, 2018-2032 (USD MILLION)
  • TABLE 161. NATO SORE THROAT LOZENGES & CANDY MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
  • TABLE 162. NATO SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. NATO SORE THROAT LOZENGES & CANDY MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 164. NATO SORE THROAT LOZENGES & CANDY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL SORE THROAT LOZENGES & CANDY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. UNITED STATES SORE THROAT LOZENGES & CANDY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 167. UNITED STATES SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. UNITED STATES SORE THROAT LOZENGES & CANDY MARKET SIZE, BY HARD LOZENGES, 2018-2032 (USD MILLION)
  • TABLE 169. UNITED STATES SORE THROAT LOZENGES & CANDY MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
  • TABLE 170. UNITED STATES SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. UNITED STATES SORE THROAT LOZENGES & CANDY MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 172. UNITED STATES SORE THROAT LOZENGES & CANDY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. CHINA SORE THROAT LOZENGES & CANDY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 174. CHINA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. CHINA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY HARD LOZENGES, 2018-2032 (USD MILLION)
  • TABLE 176. CHINA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY FLAVOR, 2018-2032 (USD MILLION)
  • TABLE 177. CHINA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. CHINA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 179. CHINA SORE THROAT LOZENGES & CANDY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)